Enrollment Barriers for Molecular Targeted Trials

JAMA Oncol. 2023 Jun 1;9(6):863-864. doi: 10.1001/jamaoncol.2023.0248.
No abstract available

Plain language summary

This quality improvement study examines the difficulties of patient accrual among patients with cancer and SETD2 variants.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Molecular Targeted Therapy*
  • Neoplasms* / drug therapy
  • Patient Selection